{"id":"W4411962974","doi":"10.3389/fimmu.2025.1601377","title":"Health impact of using anti-PD-(L)1 agents to treat early-stage cancers in Switzerland: a modeling study","year":2025,"lang":"en","type":"article","venue":"Frontiers in Immunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"Merck","keywords":"Medicine; Oncology; Internal medicine; Adjuvant; Renal cell carcinoma; Adverse effect; Population; Breast cancer; Stage (stratigraphy); Melanoma; Cancer; Triple-negative breast cancer; Adjuvant therapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001654956,0.001279759,0.0007962218,0.0009799718,0.0004712253,0.001393074,0.001228088,0.001671105,0.005128792],"category_scores_gemma":[0.003734212,0.0005029982,0.002210879,0.001077051,0.0007029045,0.0007703401,0.001005039,0.001073715,0.0002892728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004456361,"about_ca_system_score_gemma":0.002512927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1363817,"about_ca_topic_score_gemma":0.06376755,"domain_scores_codex":[0.9992285,0.0004339262,0.00001774696,0.00009329139,0.00003775746,0.0001888032],"domain_scores_gemma":[0.9968454,0.002234084,0.0003278801,0.00007728659,0.0003085717,0.0002066818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0004504841,0.000169476,0.01415449,0.00007911367,0.0001588891,0.0002545148,0.00003979865,0.9800189,0.000127301,0.001457001,0.001310125,0.001779852],"study_design_scores_gemma":[0.0005815563,0.0006133267,0.01662701,0.0001101372,0.0002819167,0.0001447089,0.0003372495,0.9769756,0.000253951,0.002433907,0.001580436,0.00006019246],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735198,0.00125965,0.005455773,0.002154808,0.00007098011,0.0001813621,0.008173438,0.00008496017,0.009099266],"genre_scores_gemma":[0.9943973,0.000474152,0.001094237,0.0001464954,0.00001833147,0.000119579,0.002097847,0.00001420433,0.001637858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1363817,"threshold_uncertainty_score":0.2711757,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02932403438758861,"score_gpt":0.3614510625051373,"score_spread":0.3321270281175486,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}